Ahrens Investment Partners LLC Zynerba Pharmaceuticals, Inc. Transaction History

Ahrens Investment Partners LLC

  • $200 Million
  • Q1 2023

A detailed history of Ahrens Investment Partners LLC transactions in Zynerba Pharmaceuticals, Inc. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 1,040 shares of ZYNE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,040
Holding current value
$0
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023
BUY
$0.4 - $0.67 $416 - $696
1,040 New
1,040 $0
Q4 2021

Jan 21, 2022
BUY
$2.88 - $4.3 $2,995 - $4,472
1,040 New
1,040 $3,000

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email